Crossmark

Postoperative hepatic arterial chemotherapy in high-risk patients as adjuvant treatment after resection of colorectal liver metastases - a randomized phase II/III trial – PACHA-01 (NCT02494973)

Crossref DOI link: https://doi.org/10.1186/s12885-018-4697-7

Published Online: 2018-08-06

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Goéré, Diane

Pignon, Jean-Pierre

Gelli, Maximiliano

Elias, Dominique

Benhaim, Léonor

Deschamps, Frédéric

Caramella, Caroline

Boige, Valérie

Ducreux, Michel

de Baere, Thierry

Malka, David
Funding

Funding for this research was provided by:

National Intitute of Cancer (PHRC-K13-272)
License Information

Text and Data Mining valid from 2018-08-06
More Information

Article History

Received: 7 August 2017

Accepted: 26 July 2018

First Online: 6 August 2018

Ethics approval and consent to participate

: This study has received the ethical approval of the Comité de Protection des Personnes – Ile de France V. N° EudraCT: 2014–005110-32 (Date of approval May 5, 2017). Informed consent signed by the patient or his/her legal representative will be obtained from the participants.

: This study does not contain individual data of person.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Document is current

Any future updates will be listed below